A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza

Clinical trial NCT00958776 · TERMINATED

Trial details

NCT number: NCT00958776
Sponsor: BioCryst Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Cough Sore Throat Nasal Congestion Headache Fever Seasonal Influenza

Start date: 2009-11-01
Primary completion: 2012-11-01
Enrollment: 405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.